Metabolon | Policies

Product Feedback Policy

Our Approach to Product Feedback

Metabolon is deeply committed to enhancing products through valuable insights and feedback from our clients, customers, team members, and prospects. We believe that your ideas and experiences are essential in guiding our product development efforts.

We use your feedback to identify critical features, innovative ideas, pain points, and growth opportunities. This collaborative approach ensures that we provide you with a more efficient and effective product experience.

How to Give Us Your Product Feedback

Providing your feedback is a seamless process at Metabolon.

Submitting Feedback: We encourage you to utilize the Feedback portal located within the MyMetabolon portal for sharing your thoughts, insights, and ideas. You can access this platform through this link or by navigating to the MyMetabolon Portal, clicking the red question mark button, clicking Feedback, and submitting your feedback.

What Happens to Your Product Feedback?

At Metabolon, we have a structured process for handling your feedback, allowing us to make informed decisions and prioritize effectively.

Awaiting Feedback: When you submit your feedback, it will initially be set to the “Awaiting Feedback” status. This status encourages more users to provide information and vote on your requests, helping us gauge demand, collect use cases, and assess potential impact and value.

Product Feedback Meetings: Every quarter, our Product Teams convene for a product feedback meeting. During these sessions, we discuss and prioritize the most crucial requests from our customers, team members, and prospects. We evaluate these requests based on popularity, impact, and resources.

Status Updates: As we review your requests, we will promptly update their status in Pendo, ensuring that you stay informed about their progress. If we decide to implement a feature or improvement, the status will change to “Planned” or “Building,” and the request will be added to our product plan. You can subscribe to feedback submissions, ensuring you receive real-time updates on the status of ideas you’ve submitted or chosen to follow. You will also be updated if a comment or question is left in the comment section of your feedback submission. Make sure to check the email associated with your MyMetabolon portal account for emails coming from feedback@metabolon.com.

Transparent Communication: Our product feedback portal always provides up-to-date information about our products and plans. We are committed to offering clear explanations for any status updates.

If you prefer to reach out directly to our Support or Customer Success teams, they can assist you in finding relevant ideas, although they may not have additional information or estimates regarding the review timeline.

FAQs

How long will it be before the product team reviews my idea?

Our product specialists review items monthly, allowing us to prioritize and update requests regularly. Quarterly roadmapping meetings help us align these requests with our strategic goals. To increase the likelihood of your request being considered, ensure it is clear, concise, and easy for others to understand and prioritize.

My request has not been reviewed yet, and I submitted it 6+ months ago. What can I do?

If your high-priority request has not been reviewed within six months:

Make sure your request stays at the top of your priority list.

Clarify your request’s significance by explaining why you need it, what it prevents you from doing, and its potential impact. You can add these details in a comment on your idea.

We greatly appreciate your feedback, understanding, and support as we collaborate to create the best possible products at Metabolon!

Is there a limit to the number of feedback submissions I can make?

There is no limit to the number of feedback submissions you can make. We encourage you to share your ideas and experiences as often as needed to help us improve our products continually.

Will I receive updates on the status of my feedback submission?

Yes, if you subscribe to a submission (yours or other submissions you want updates on) you will receive updates via the email associated with your MyMetabolon portal account from feedback@metabolon.com. We aim to keep you informed about the progress of your requests.

Can I edit or withdraw my feedback after submitting it?

Yes, you can edit or withdraw your feedback after submission. If you have additional information or wish to modify your request, simply navigate to the MyMetabolon portal, and update it within the Pendo Feedback platform.

How are feedback submissions prioritized?

Feedback submissions are prioritized based on a range of factors, including the number of votes, the alignment with our product and company strategy, resources, and the potential impact on our user community. Clear and detailed submissions are more likely to receive attention.

References

1. Zgoda-Pols, J.R., et al., Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: investigation of nicotinic acid receptor agonists. Toxicol Appl Pharmacol, 2011. 255(1): p. 48-56.

2. Bryant, J.A., et al., The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiome. Nat Med, 2026. 32(1): p. 186-196

3. McGovern, B .H., et al., SER-109, an Investigational Microbiome Drugto Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial. Clin Infect Dis, 2021. 72(12): p. 2132-2140.

4. Feuerstadt, P., et al., SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. N Engl J Med, 2022. 386(3): p. 220-229.

5. Hu, Z., et al., Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer. Mol Oncol, 2025. 19(6): p. 1737-1750.

6. Butler, F.M., et al., Vegetarian Dietary Patterns and Diet-Related Metabolites Are Associated With Kidney Function in the Adventist Health Study-2 Cohort. J Ren Nutr, 2025.

7. Stanford, J., et al., Metabolomic Profiling and Diet Quality Scoring in a Randomized Crossover Trial of Healthy and Typical Dietary Patterns. Mol Nutr Food Res, 2025 . 69(23): p. e70271.

8. O’Connor, L.E., et al., Metabolomic Profiling of an Ultraprocessed Dietary Pattern in a Domiciled Randomized Controlled Crossover Feeding Trial. J Nutr, 2023. 153(8): p. 2181-2192.

9. Fritsch, D.A., et al., Microbiome function underpins the efficacy of a fiber-supplemented dietary intervention in dogs with chronic large bowel diarrhea. BMC Vet Res, 2022. 18(1): p. 245.

10. Leal, L.N., et al., Preweaning nutrient supply improves lactation productivity and reduces the risk of culling in Holstein cows. J Dairy Sci, 2025. 108(6): p. 5875-5888.

11. Ahsin, M., et al., Soil and pasture health underlie improved beef nutrient density determined by untargeted metabolomics in Southern US grass finished beef systems. NPJ Sci Food, 2025. 9(1): p. 151.

12. Yin, W., et al., Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J Lipid Res, 2012. 53(1): p. 51-65.

13. Porter, F .D., et al., Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med, 2010. 2(56): p. 56ra81.

14. Needham, B .D., et al., Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder. Biol Psychiatry, 2021. 89(5): p. 451-462

15. Li, C., et al., Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells. J Exp Med, 2014. 211(1): p. 15-28.

16. Green, P.G., et al., Metabolic flexibility and reverse remodelling of the failing human heart. Eur Heart J, 2025. 46(25): p. 2422-2433.

17. Maekawa, H., et al., SGLT2 inhibition protects kidney function by SAM-dependent epigenetic repression of inflammatory genes under metabolic stress. J Clin Invest, 2025. 135(19).

18. Wu, D., et al., Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibition. Gut, 2026.

19. Schwerdtfeger, L.A., et al., Gut microbiota and metabolites are linked to disease progression in multiple sclerosis. Cell Rep Med, 2025. 6(4): p. 102055.

20. Wu, H., et al., Microbiome-metabolome dynamics associated with impaired glucose control and responses to lifestyle changes. Nat Med, 2025. 31(7): p. 2222-2231.

21. Jacobs, J.P., et al., Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement. Microbiome, 2021. 9(1): p. 236.

22. Pietzner, M., et al., Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. Nat Med, 2021. 27(3): p. 471-479.

23. Faquih, T.O., et al., Robust Metabolomic Age Prediction Based on a Wide Selection of Metabolites. J Gerontol A Biol Sci Med Sci, 2025. 80(3).

24. Scherer, N., et al., Coupling metabolomics and exome sequencing reveals graded effects of rare damaging heterozygous variants on gene function and human traits. Nat Genet, 2025. 57(1): p. 193-205.

25. Holmes, Z.C., et al., Untargeted metabolomic analysis of human milk from healthy mothers reveals drivers of metabolite variability. Sci Rep, 2024. 14(1): p. 20827.

26. Titz, B., et al., Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases. Transl Vis Sci Technol, 2024. 13(6): p. 17.

27. Bloom, S.M., et al., Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation. Nat Microbiol, 2022. 7(3): p. 434-450.

28. Leimer, E.M., et al., Lipid profile of human synovial fluid following intra-articular ankle fracture. J Orthop Res, 2017. 35(3): p. 657-666.